We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.6B
AUM Growth
+$69.6M
Cap. Flow
+$51.5M
Cap. Flow %
0.92%
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62

Top Sells

Rank Stock Value
1
PII icon
Polaris
PII
+$36M
2
TROW icon
T. Rowe Price
TROW
+$31.5M
3
ELV icon
Elevance Health
ELV
+$27.8M
4
ITC
ITC HOLDINGS CORP
ITC
+$26.5M
5
AMAT icon
Applied Materials
AMAT
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 19.08%
2 Financials 18.2%
3 Consumer Discretionary 11.88%
4 Technology 11.08%
5 Industrials 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
151
Kinder Morgan
KMI
$70.2B
$3.49M 0.06%
90,817
+1,838
+2% +$76.7K
NVO
152
Novo Nordisk
NVO
$205B
$3.46M 0.06%
126,370
-34,156
-21% -$960K
T icon
153
AT&T
T
$174B
$3.42M 0.06%
127,431
-5,146
-4% -$133K
CVX icon
154
Chevron
CVX
$392B
$3.4M 0.06%
35,197
+3,385
+11% +$355K
EEM icon
155
iShares MSCI Emerging Markets ETF
EEM
$31.4B
$3.35M 0.06%
84,452
+3,059
+4% +$128K
AMTX icon
156
Aemetis
AMTX
$135M
$3.34M 0.06%
927,105
+84,937
+10% +$371K
TYG
157
Tortoise Energy Infrastructure Corp
TYG
$1.1B
$3.33M 0.06%
22,540
-853
-4% -$143K
TROW icon
158
T. Rowe Price
TROW
$24B
$3.31M 0.06%
42,637
-390,269
-90% -$31.5M
TRIB
159
Trinity Biotech
TRIB
$7.93M
$3.25M 0.06%
1,201
+168
+16% +$436K
DD
160
DELISTED
Du Pont De Nemours E I
DD
$3.24M 0.06%
53,306
-127
-0.2% -$8.55K
ACN icon
161
Accenture
ACN
$115B
$3.09M 0.06%
31,950
+36
+0.1% +$3.44K
PM icon
162
Philip Morris
PM
$297B
$3.09M 0.06%
38,551
+1,691
+5% +$139K
FNGN
163
DELISTED
Financial Engines, Inc.
FNGN
$3.08M 0.06%
72,415
+6,402
+10% +$272K
LOPE icon
164
Grand Canyon Education
LOPE
$3.91B
$3.07M 0.05%
72,420
+14,893
+26% +$645K
TM icon
165
Toyota
TM
$227B
$3.07M 0.05%
22,963
+1,557
+7% +$215K
ESRX
166
DELISTED
Express Scripts Holding Company
ESRX
$3.03M 0.05%
34,048
+3,177
+10% +$278K
GLD icon
167
SPDR Gold Trust
GLD
$154B
$3.01M 0.05%
26,796
-1,077
-4% -$123K
SIG icon
168
Signet Jewelers
SIG
$3.18B
$2.97M 0.05%
23,169
-3,831
-14% -$513K
TTM
169
DELISTED
Tata Motors Limited
TTM
$2.96M 0.05%
85,993
-716
-0.8% -$28.5K
PSXP
170
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$2.91M 0.05%
40,475
+2,220
+6% +$160K
NGLS
171
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$2.9M 0.05%
75,131
-982
-1% -$42.5K
BAX icon
172
Baxter International
BAX
$13.4B
$2.83M 0.05%
74,566
+120
+0.2% +$4.49K
NVS icon
173
Novartis
NVS
$294B
$2.77M 0.05%
31,478
+3,326
+12% +$305K
ORCL icon
174
Oracle
ORCL
$438B
$2.73M 0.05%
67,798
+5,853
+9% +$254K
HON icon
175
Honeywell
HON
$69.9B
$2.73M 0.05%
29,802
+20
+0.1% +$1.86K

Similar funds

Geneva Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
  • Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
  • Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
  • Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
  • Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
  • Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.

Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.